by Olivia Dimmer, Northwestern University Credit: Wikimedia CommonsAn experimental drug designed to block blood-clotting proteins may lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology. More than 795,000 people in the United States each year suffer a stroke, according to the American Heart Association, and nearly 1 in 5...
